Market Forecast for May 12–16, 2025

ljubaphoto/E+ via Getty Images A Quick Take On Actuate Therapeutics, Inc. Actuate Therapeutics, Inc. (ACTU) has filed to raise $50 million in an IPO of its common stock, according to SEC S-1 registration information. The firm is a clinical-stage biopharma developing treatments for pancreatic cancers and other cancer conditions. Actuate Therapeutics, Inc. has shown promising…

StockNews.com cut shares of AT&T from a “buy” rating to a “hold” rating in a research note on Thursday. Source link

Klöckner & Co SE (KLKNF) Worthington Steel, Inc. – M&A Call – Slideshow Source link

EUR/NZD – Continues Downward March Source link

share this article! [#item_full_content] Read More share this article! Source link